These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6347194)

  • 1. Disturbance of lysosomal glycogen metabolism by liposomal anti-alpha-glucosidase and some anti-inflammatory drugs.
    Geddes R; Otter DE; Scott GK; Taylor JA
    Biochem J; 1983 Apr; 212(1):99-103. PubMed ID: 6347194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal glycogen storage induced by Acarbose, a 1,4-alpha-glucosidase inhibitor.
    Geddes R; Taylor JA
    Biochem J; 1985 Jun; 228(2):319-24. PubMed ID: 3893420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal glycogen storage mimicking the cytological picture of Pompe's disease as induced in rats by injection of an alpha-glucosidase inhibitor. I. Alterations in liver.
    Lüllmann-Rauch R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 38(1):89-100. PubMed ID: 6119839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal storage of glycogen as a sequel of alpha-glucosidase inhibition by the absorbed deoxynojirimycin derivative emiglitate (BAYo1248). A drug-induced pattern of hepatic glycogen storage mimicking Pompe's disease (glycogenosis type II).
    Lembcke B; Lamberts R; Wöhler J; Creutzfeldt W
    Res Exp Med (Berl); 1991; 191(6):389-404. PubMed ID: 1775731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal glycogen accumulation in rat liver and its in vivo kinetics after a single intraperitoneal injection of acarbose, an alpha-glucosidase inhibitor.
    Konishi Y; Okawa Y; Hosokawa S; Fujimori K; Fuwa H
    J Biochem; 1990 Feb; 107(2):197-201. PubMed ID: 2193931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the metabolic control of cytosolic and lysosomal glycogen levels in the liver.
    Geddes R; Taylor JA
    Biosci Rep; 1985 Apr; 5(4):315-20. PubMed ID: 3896336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acarbose is a competitive inhibitor of mammalian lysosomal acid alpha-D-glucosidases.
    Calder PC; Geddes R
    Carbohydr Res; 1989 Aug; 191(1):71-8. PubMed ID: 2776140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and metabolic aspects of lysosomal glycogen.
    Geddes R; Jeyarathan P; Taylor JA
    Carbohydr Res; 1992 Apr; 227():339-49. PubMed ID: 1499032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alpha-amylase and alpha-glucosidase inhibitors on caries incidence and plaque accumulation in rats.
    Mörmann JE; Schmid R; Mühlemann HR
    Caries Res; 1983; 17(4):353-6. PubMed ID: 6191863
    [No Abstract]   [Full Text] [Related]  

  • 10. Post mortem glycogenolysis is a combination of phosphorolysis and hydrolysis.
    Calder PC; Geddes R
    Int J Biochem; 1990; 22(8):847-56. PubMed ID: 2279618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of weight gain by an alpha-glucosidase inhibitor during refeeding in rats.
    Kotler DP; Tierney AR; Kral JG; Bjorntorp P
    Am J Clin Nutr; 1984 Aug; 40(2):270-6. PubMed ID: 6380264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of inhibition of intestinal glucosidase on protein and energy balance in rats].
    Kirchgessner M; Spoerl R; Roth FX
    Ann Nutr Metab; 1981; 25(3):194-200. PubMed ID: 7025747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of alpha-glucosidase inhibition on intestinal disaccharidase activity in normal and diabetic mice.
    Lee SM; Bustamante SA; Koldovský O
    Metabolism; 1983 Aug; 32(8):793-9. PubMed ID: 6346004
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nutrient digestibility and N-balance after administration of an alpha-glucosidase inhibitor to pigs].
    Roth FX; Kirchgessner M
    Z Tierphysiol Tierernahr Futtermittelkd; 1980; 44(2):57-63. PubMed ID: 6252715
    [No Abstract]   [Full Text] [Related]  

  • 15. Exocrine and endocrine pancreatic function in rats treated with alpha-glucosidase inhibitor (acarbose).
    Otsuki M; Sakamoto C; Ohki A; Okabayashi Y; Yuu H; Maeda M; Baba S
    Metabolism; 1983 Aug; 32(8):846-50. PubMed ID: 6191180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of pseudo-aminosugars on oligosaccharide glucosidases I and II and on lysosomal alpha-glucosidase from rat liver.
    Takeuchi M; Kamata K; Yoshida M; Kameda Y; Matsui K
    J Biochem; 1990 Jul; 108(1):42-6. PubMed ID: 2229010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Puls W
    Digestion; 1982; 23(4):232-8. PubMed ID: 6754513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glucose oligomers on the glycogen levels of isolated hepatocytes.
    Lichtenberg L; Sugg RG; Villar-Palasi C
    Arch Biochem Biophys; 1984 Aug; 232(2):654-9. PubMed ID: 6547815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation of the small intestine to induced maldigestion in rats. Experimental pancreatic atrophy and acarbose feeding.
    Creutzfeldt W; Fölsch UR; Elsenhans B; Ballmann M; Conlon JM
    Scand J Gastroenterol Suppl; 1985; 112():45-53. PubMed ID: 3892654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modification of carbohydrate metabolism and oral glucose tolerance test in type II diabetics using the glucosidase inhibitor acarbose].
    Schwartzkopff W; Calder D
    Med Welt; 1984 Feb; 35(6):169-74. PubMed ID: 6369065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.